Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.88 USD | +2.95% | +10.41% | +14.55% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 302M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -119M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.38
x | P/E ratio 2025 * |
-3.1
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Inozyme Pharma, Inc.
1 day | +2.95% | ||
1 week | +10.41% | ||
Current month | +10.66% | ||
1 month | -23.87% | ||
3 months | -9.46% | ||
6 months | +63.21% | ||
Current year | +14.55% |
Managers | Title | Age | Since |
---|---|---|---|
Axel Bolte
FOU | Founder | 52 | 15-08-31 |
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 20-04-30 |
Director of Finance/CFO | 48 | 22-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 20-04-30 |
Reinaldo Diaz
BRD | Director/Board Member | 70 | 16-12-31 |
Axel Bolte
FOU | Founder | 52 | 15-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 4.88 | +2.95% | 354,520 |
24-05-03 | 4.74 | +1.94% | 327,045 |
24-05-02 | 4.65 | +0.87% | 567,822 |
24-05-01 | 4.61 | +4.54% | 510,705 |
24-04-30 | 4.41 | -0.23% | 638,247 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.55% | 293M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- INZY Stock